Recently the American Urological Association (AUA) announced new guidelines for prostate specific antigen (PSA) testing. These guidelines were designed to help urologists, and ultimately patients, reduce prostate cancer mortality by making informed screening decisions. These recommendations were based on comprehensive literature reviews and the strength of the existing evidence.
Dr. David Samadi, a world-renowned prostate cancer surgeon is all set to conduct free prostate cancer screenings at the Chian Federation, 4401 Broadway in Astoria, New York 11103 on Saturday, February 16 2013. Men who attend this screening event will receive Prostate-specific antigen (PSA) blood tests and/or digital rectal exams (DRE) at no charge between...
The controversial decision of the United States Preventative Services Task Force (USPSTF) to recommend against screening men for prostate cancer has prompted a healthy debate regarding the utility of the early detection of this cancer. Despite our best efforts for early detection, prostate cancer remains the second leading cancer cause of death in men, killing...Continue reading
Richard J. Ablin, research professor of immunobiology at the University of Arizona College of Medicine, has been studying prostate cancer for over 40 years. After discovering the Prostate-Specific Antigen (PSA), an enzyme made by the prostate, and subsequent approval by the Food and Drug Administration in 1994, the PSA test is the most commonly used...